NeuroPace (NPCE) Receivables - Net (2020 - 2026)
NeuroPace's (NPCE) quarterly Receivables - Net came in at $14.8 million in Q1 2026, down 4.19% year-on-year from $15.4 million in Q1 2025, and up 0.73% quarter-over-quarter from $14.7 million in Q4 2025.
NeuroPace (NPCE) Receivables - Net (2020 - 2026) Analysis & Trends
NeuroPace's Receivables - Net history runs 7 years deep, the most recent figure standing at $14.8 million for Q1 2026.
- On a quarterly basis, Receivables - Net fell 4.19% year-over-year to $14.8 million in Q1 2026; TTM through Mar 2026 was $14.8 million, a 4.19% decrease from a year earlier, with the FY2025 full-year figure at $14.7 million, up 13.95% from the prior year.
- Receivables - Net grew to $14.8 million in Q1 2026 per NPCE's latest filing, from $14.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $15.4 million in Q1 2025 and bottomed at $7.5 million in Q4 2022.
- The 5-year median for Receivables - Net is $11.6 million (2024), against an average of $11.6 million.
- Across the five-year window, Receivables - Net surged 64.39% in 2023 and decreased 4.19% in 2026, its largest moves.
- Year by year, Receivables - Net stood at $7.5 million in 2022, then jumped by 64.39% to $12.3 million in 2023, then increased by 4.48% to $12.9 million in 2024, then climbed by 14.24% to $14.7 million in 2025, then climbed by 0.73% to $14.8 million in 2026.
- Per Business Quant, the three latest NPCE Receivables - Net figures stand at $14.8 million (Q1 2026), $14.7 million (Q4 2025), and $14.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.79 Mn |
| Mar 31, 2026 | 14.79 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 14.94 Mn |
| Sep 30, 2025 | 14.94 Mn |
| Jun 30, 2025 | 13.55 Mn |
| Jun 30, 2025 | 13.55 Mn |
| Mar 31, 2025 | 15.44 Mn |
| Mar 31, 2025 | 15.44 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 11.56 Mn |
| Sep 30, 2024 | 11.56 Mn |
| Jun 30, 2024 | 11.24 Mn |
| Jun 30, 2024 | 11.24 Mn |
| Mar 31, 2024 | 11.63 Mn |
| Mar 31, 2024 | 11.63 Mn |
| Dec 31, 2023 | 12.30 Mn |
| Dec 31, 2023 | 12.30 Mn |